Brief: Diamyd Medical Gets Notice Of Allowance For Retogatein U.S. Patent

Diamyd Medical AB

09/02/2026 08:47

Feb 9 (Reuters) - Diamyd Medical AB DMYDb.ST:

PATENT, WHEN ISSUED, WILL HAVE AN ANTICIPATED EXPIRATION DATE IN 2035

DIAMYD MEDICAL RECEIVES NOTICE OF ALLOWANCE FOR KEY RETOGATEIN US PATENT

Source text: ID:nWkr8Jw6nL

Further company coverage: [DMYDb.ST]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))